by Dr. Corey Cutler, MD, MPH
In the December President's Message, Dr. Corey Cutler, MD, MPH, reflects on an impactful year for ASTCT.
by Alex Kadhim
Researchers at Stanford University have conducted a phase 1 clinical trial (#NCT03233854) evaluating the combination of a bispecific chimeric antigen receptor (CAR) T-cell therapy targeting CD19...
by ASTCT Talks
Welcome to the second installment of an exclusive 8-part ASTCT Talks series, supported by an educational grant from Sanofi US.
by BJHaem
The potential for secondary myelodyspastic syndromes (MDS) following chimeric antigen receptor (CAR) T-cell therapy in children with acute lymphoblastic leukemia (ALL) is a real concern,...
by ASTCT
The following infographics are based on New Developments in CAR T Treatments Webinar Series, which aired on Tuesday, September 10, at 12 p.m. CDT and featured two presentations from Drs....
by Alex Kadhim
The "New Developments in CAR T Treatments" webinar series, held on September 10, 2024, brought together leading experts in the field of cancer immunotherapy to discuss the latest...